-
Meta-analyses of biased RCTs give biased results, even on individual data - Authors' repl
Author: Sun, Yingxian; Li, Jing
Journal: LANCET. 2026; Vol. 407, Issue 10538, pp. 1511-1512. DOI: 10.1016/S0140-6736(26)00549-0
-
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 stud
Author: Colombo, Nicoletta; Zsiros, Emese; Parma, Gabriella; Rulli, Eliana; Sebastianelli, Alexandra; Bidzinski, Mariusz; Gallardo, Carlos; Matanes, Emad; Hasegawa, Kosei; Kose, Fatih; Magallanes-Maciel, Manuel; Herbertson, Rebecca A.; Ananda, Sumitra; Kroep, Judith R.; de Melo, Andreia Cristina; Debruyne, Philip R.; Kim, Jae-Weon; Sehouli, Jalid; Pierre, Marc-Edy; Hietanen, Sakari; Zamagni, Claudio; Lu, Xin; Monk, Bradley J.; Coleman, Robert L.; Peng, Xuan; Yamada, Karin; Bogusz, Agata M.; Rouge, Thibault De La Motte; Wu, Xiaohua
Journal: LANCET. 2026; Vol. 407, Issue 10538, pp. 1525-1537. DOI: 10.1016/S0140-6736(26)00602-1
-
Perioperative immunotherapy for resectable hepatocellular carcinom
Author: Li, Zhenli; Tang, Yufu
Journal: LANCET. 2026; Vol. 407, Issue 10536, pp. 1332-1332. DOI:
-
Autosomal dominant polycystic kidney diseas
Author: Ong, Albert C. M.; Carriazo, Sol; Ma, Becky Mingyao; Torra, Roser; Pei, York
Journal: LANCET. 2026; Vol. 407, Issue 10535, pp. 1289-1302. DOI: 10.1016/S0140-6736(26)00046-2
-
Safeguarding against dengue fever risks in a more connected worl
Author: Chan, Emily Ying Yang; Leung, Chun-ying; Dubois, Caroline; Yung, Louise; Huang, Zhe
Journal: LANCET. 2026; Vol. 407, Issue 10534, pp. 1141-1142. DOI: 10.1016/S0140-6736(26)00323-5
-
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial-Authors' repl
Author: Chen, Zhiwei; Lu, Shun
Journal: LANCET. 2026; Vol. 407, Issue 10534, pp. 1146-1146. DOI: 10.1016/S0140-6736(26)00295-3
-
Angiography-derived fractional flow reserve versus coronary angiographyto guide coronary artery bypass grafting in patients undergoing surgical valve procedures with concomitant coronary artery disease in China (FAVOR IV-QVAS): a multicentre, triple-blind, randomised tria
Author: Zhu, Yunpeng; Cheng, Zhaoyun; Zhao, Yuan; Han, Lin; Zhang, Wei; Zhang, Chengxin; Yang, Sumin; Ma, Liang; Qiao, Chenhui; Guo, Zhigang; Zhu, Dan; Zhang, Xiquan; Chen, Liangwan; Wang, Zhe; Ye, Xiaofeng; Zhou, Mi; Li, Haiqing; Qiu, Jiapei; Xu, Hong; Sun, Yanjun; Zhu, Jiaxi; Xu, Zhiyun; Qin, Guoyou; Wijns, William; Redfors, Bjorn; Sandner, Sigrid; Gaudino, Mario; Tu, Shengxian; Zhao, Qiang
Journal: LANCET. 2026; Vol. 407, Issue 10534, pp. 1161-1170. DOI:
-
PD-L1, treatment intensity, and outcomes in squamous NSCL
Author: Xu, Xiaoling; Wang, Wenjing; Li, Huihui; Hu, Xuefei
Journal: LANCET. 2026; Vol. 407, Issue 10534, pp. 1145-1146. DOI: 10.1016/S0140-6736(26)00144-3